cjc-1295 ipamorelin benefits side effects studies CJC-1295/Ipamorelin General Info Sheet CJC-1295 Ipamorelin is a synthetic

K., Kato C

10.1016/j.xcrm.2020.100005 10.1016/j.xcrm.2020.100005 [DOI] [PMC free article] [PubMed] [Google Scholar] Glorieux C, Calderon PB (2017) Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach

Archivos Argentinos de Pediatria 2012;110(4):2916

GLP-1 medications work by mimicking the incretin hormone glucagon-like peptide-1, which enhances insulin secretion in response to food, suppresses glucagon release, slows gastric emptying, and reduces appetite

Additionally, there are Nrf2 target enzymes such as aldehyde dehydrogenase 1 family member A1 (ALDH1A1), which oxidizes aldehydes to the carboxylic acid form, and glucose 6-phosphate dehydrogenase (G6PD), which is responsible for glucose metabolism/NAPDH neurodegeneration (Thimmulappa et al